Sumitomo Mitsui Trust Group Inc. Grows Position in Smartstop Self Storage REIT Inc $SMA

Sumitomo Mitsui Trust Group Inc. raised its position in Smartstop Self Storage REIT Inc (NYSE:SMA) by 67.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,419 shares of the healthcare company’s stock after purchasing an additional 23,145 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.10% of Smartstop Self Storage REIT worth $1,777,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of SMA. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Smartstop Self Storage REIT in the 3rd quarter worth about $26,000. Raymond James Financial Inc. purchased a new position in shares of Smartstop Self Storage REIT in the 2nd quarter worth about $35,000. CoreCap Advisors LLC purchased a new position in shares of Smartstop Self Storage REIT in the 4th quarter worth about $37,000. Canton Hathaway LLC purchased a new position in shares of Smartstop Self Storage REIT in the 4th quarter worth about $39,000. Finally, Avalon Trust Co purchased a new position in shares of Smartstop Self Storage REIT in the 3rd quarter worth about $40,000.

Smartstop Self Storage REIT Stock Performance

Shares of NYSE:SMA opened at $33.21 on Friday. Smartstop Self Storage REIT Inc has a one year low of $29.42 and a one year high of $39.77. The business’s 50-day simple moving average is $32.06 and its 200 day simple moving average is $32.88. The company has a debt-to-equity ratio of 0.86, a quick ratio of 5.87 and a current ratio of 5.87. The company has a market cap of $1.84 billion and a P/E ratio of -89.75.

Smartstop Self Storage REIT (NYSE:SMA) last issued its quarterly earnings data on Wednesday, February 25th. The healthcare company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.54 by ($0.49). Smartstop Self Storage REIT had a negative net margin of 0.59% and a negative return on equity of 0.16%. The business had revenue of $78.45 million for the quarter. The firm’s revenue for the quarter was up 29.5% on a year-over-year basis. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.930-2.050 EPS.

Smartstop Self Storage REIT Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 30th will be paid a dividend of $0.1315 per share. This represents a c) dividend on an annualized basis and a yield of 4.8%. The ex-dividend date is Thursday, April 30th. Smartstop Self Storage REIT’s dividend payout ratio (DPR) is -440.54%.

Analysts Set New Price Targets

SMA has been the topic of several analyst reports. Truist Financial dropped their target price on Smartstop Self Storage REIT from $39.00 to $38.00 and set a “buy” rating on the stock in a report on Tuesday, January 20th. Robert W. Baird dropped their target price on Smartstop Self Storage REIT from $37.00 to $36.00 and set an “outperform” rating on the stock in a report on Wednesday, March 11th. Scotiabank upgraded Smartstop Self Storage REIT to a “strong-buy” rating in a report on Thursday, March 19th. Wall Street Zen upgraded Smartstop Self Storage REIT from a “sell” rating to a “hold” rating in a report on Saturday, March 7th. Finally, Wells Fargo & Company dropped their target price on Smartstop Self Storage REIT from $33.00 to $30.00 and set an “equal weight” rating on the stock in a report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, one has assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, Smartstop Self Storage REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.25.

Smartstop Self Storage REIT Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.